[1]
Sarsik, S. et al. 2026. Comparative Efficacy and Safety of Tapinarof 0.5% and 1% Cream Regimens for Atopic Dermatitis: A Network Meta-Analysis. Dermatology Practical & Conceptual. 16, 1 (Jan. 2026), 6042. DOI:https://doi.org/10.5826/dpc.1601a6042.